T
Taysha Gene Therapies, Inc.
TSHA · NASDAQ · Healthcare · 1.9B
Price · close
$6.09
-0.33% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
7.9×
Enterprise value / EBITDAEV/EBITDA
-15.3×
Free cash flow yieldFCF yield
-4.8%
Return on equityROE
-44.1%
Operating margin
-1130.6%
Net debt / EBITDAbalance-sheet strength
2.8×
Interest coverage
-1753.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.